Updates in Pompe Disease

Muscular Dystrophy Association

B. K. Burton

Year in Review: Muscle Ultrasound - Highlights Update

Nens Van Alfen

Impact of Combination Therapies and Exercise Programs for Neuromuscu…

The France Foundation

A. Veerapandiyan, J. Brandsema, L. Servais

Emerging Therapies for Neuromuscular Diseases in 2021: ALS, Dystroph…

Houston Methodist

E. Greene

Non-Dystrophin Muscular Dystrophies: Gene Variants & Clinical Featur…

ZINCARE

D. Leung

Functional Biomarkers for Muscular Dystrophy

The France Foundation

J. Brandsema, L. Servais, A. Veerapandiyan

Advanced Imaging in Neurological Diseases: Mind the Gap

University at Buffalo Neurology Department

N. Bergsland

Myotonic Dystrophy (DM): Core Features, Clinical Subtypes, and Outco…

Muscular Dystrophy Association

N. Johnson

Facioscapulohumeral Muscular Dystrophy

Vineeth Jaison

S. S Nair, U. Kalane

Heterogeneity in Muscular Dystrophies

The France Foundation

L. Servais, J. Brandsema

Registries and Natural History Studies in DMD

The France Foundation

L. Servais, J. Brandsema

Neuromuscular Cases: Lessons From Fellowship

University of Miami

A. Shahein

Pediatric Neuromuscular Disorders

ZINCARE

J. Wilmshurst

Case Discussion: DMD

The France Foundation

C. Proud, A. Veerapandiyan, C. Mcdonald

Gait Analysis in Your Pocket

NYU Langone Orthopedic Webinar Series

M. Karamitopoulos

Current Management of Spinal Muscular Atrophy

University of Miami

M. Saporta

DMD Management in the Era of Gene Therapy

The France Foundation

A. Veerapandiyan, C. Zaidman

Orthopaedic Management of Cerebral Palsy

UCSF School of Medicine

R. Brar

Clinical Pearls: Assessment & Management of ME/CFS and Long COVID

Bateman Horne Center

J. Bell

Duchenne Muscular Dystrophy and Gene Therapy: What's On the Horizon?

The France Foundation

H. Abdel-Hamid, A. Veerapandiyan